8-K/A: DENTSPLY SIRONA Details CFO Matthew Garth's Separation Terms
Executive Separation Agreement Amendment
DENTSPLY SIRONA Inc. filed an amendment to its 8-K, detailing the separation agreement with former Executive Vice President and CFO Matthew E. Garth, including severance payments and equity treatment.
Summary
- Matthew E. Garth ceased to serve as the Executive Vice President and Chief Financial Officer of DENTSPLY SIRONA Inc. effective November 5, 2025.
- The Company entered into a Separation and Release of Claims Agreement with Mr. Garth on November 7, 2025.
- Mr. Garth will receive separation payments totaling $1,200,000, payable in two installments of $600,000 each.
- An amount equal to $32,430 will be paid, representing twelve months of COBRA premiums for continuation of medical, dental, and vision insurance coverage.
- Mr. Garth remains eligible to earn a prorated portion (5/36ths) of the performance restricted share units granted on May 30, 2025, based on actual performance attainment.
- Outplacement services will be provided for twelve months following the Separation Date.
- All other unvested portions of Mr. Garth's equity awards will be forfeited and canceled for no consideration.
- Receipt of these separation payments and benefits is contingent on Mr. Garth's timely execution and nonrevocation of a release of claims and compliance with post-termination obligations, including restrictive covenants.
Sentiment
Score: 5
Explanation: The filing provides factual details about an executive separation, which is a common corporate event. The financial impact is quantifiable but not overwhelmingly positive or negative in the context of a large public company, thus maintaining a neutral sentiment.
Positives
- The company has formalized the terms of the executive separation, providing clarity on financial obligations and post-employment covenants.
- The separation agreement includes restrictive covenants and a release of claims, protecting the company's interests.
Negatives
- The company will incur significant separation payments totaling $1,200,000 in cash, plus $32,430 for COBRA premiums and prorated equity.
- The departure of a key executive like the CFO can introduce uncertainty regarding financial leadership and strategy.
Risks
- Mr. Garth's receipt of separation benefits is contingent on his compliance with post-termination obligations; any breach could lead to termination of benefits.
- The company makes no representations that the payments and benefits comply with Section 409A of the Internal Revenue Code, and will not be liable for any related taxes, penalties, or interest incurred by Mr. Garth.
Future Outlook
No specific forward-looking statements regarding company performance or financial guidance were provided in this filing, which focuses solely on executive separation terms.
Management Comments
- Daniel T. Scavilla, President and Chief Executive Officer, signed the Form 8-K/A on behalf of DENTSPLY SIRONA Inc.
- Andrea Frohning, Senior Vice President, Chief Human Resources Officer, signed the Separation and Release of Claims Agreement on behalf of DENTSPLY SIRONA Inc.
Industry Context
This filing primarily addresses an internal corporate governance matter related to executive separation and does not provide information directly linking to broader industry trends or competitive landscape.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Executive Vice President and Chief Financial Officer | Matthew E. Garth | Not specified in this filing | November 5, 2025 | Will no longer serve |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Executive Compensation/Separation Terms | Formalization of separation terms for former CFO Matthew E. Garth, including severance, COBRA benefits, and treatment of equity awards. | November 7, 2025 | Provides clarity on financial obligations and ensures adherence to restrictive covenants following a key executive's departure. |
Legal Proceedings
- The agreement includes a comprehensive release of claims by Matthew E. Garth against DENTSPLY SIRONA Inc. and its affiliates, covering a wide range of potential legal actions related to his employment and separation.
Stakeholder Impact
- Shareholders: Gain clarity on the financial costs associated with the former CFO's departure and the terms ensuring compliance with post-employment obligations.
- Employees: The departure of a senior executive may lead to internal adjustments, but the filing does not detail broader employee impact.
- Management: The agreement ensures that the former CFO adheres to confidentiality and non-competition clauses, protecting company interests.
Next Steps
- Payment of the first $600,000 separation installment on the first regularly scheduled payroll date following the agreement becoming effective and irrevocable.
- Payment of the second $600,000 separation installment on the first regularly scheduled payroll date at least three months after the first payment date.
- Settlement of the Prorated PRSUs, if any, following the conclusion of the applicable performance period.
- Mr. Garth's continued compliance with post-termination obligations and restrictive covenants.
Key Dates
| Date | Description |
|---|---|
| May 15, 2025 | Date of the Offer Letter for Matthew E. Garth's employment as Executive Vice President & Chief Financial Officer. |
| May 30, 2025 | Date of original grant of performance restricted share units to Matthew E. Garth. |
| November 5, 2025 | Effective date Matthew E. Garth ceased to serve as Executive Vice President and Chief Financial Officer (Separation Date). |
| November 6, 2025 | Date of the Original Report on Form 8-K reporting Mr. Garth's departure. |
| November 7, 2025 | Date the Company entered into the Separation and Release of Claims Agreement with Matthew E. Garth. |
Recommendation
holdThis filing provides details on the separation agreement for a former CFO, which is a standard corporate event following an executive departure. It clarifies financial obligations and restrictive covenants but does not introduce new information that would fundamentally alter the company's operational outlook or financial health to warrant a change in investment stance. Investors should monitor the appointment of a new CFO and any subsequent strategic shifts.
Keywords
DENTSPLY SIRONA, XRAY, CFO, Executive Departure, Separation Agreement, Severance, Corporate Governance, SEC Filing, Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.